The global primary care point-of-care (POC) diagnostics market is expected to grow at a rate of 7% during 2024 and 2032, driven by technological advancements, and the growing demand for rapid & accurate diagnostic solutions.

According to WHO, NCDs claim 41 million lives annually, comprising 74% of global fatalities. The rising geriatric population, coupled with the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases is pushing the demand for POC diagnostic tools. Additionally, the growing demand for decentralized diagnostic testing, in consort with the advancements in technology, such as the development of portable diagnostic devices, are enhancing patient convenience and driving adoption rates.

There is improved awareness about the early diagnosis of ailments. This factor, alongside favorable government initiatives and reimbursement policies are encouraging healthcare providers to integrate POC diagnostics into their practices, fostering market expansion.

The overall primary care POC diagnostics industry is classified based on product, end-use, and region.
The cardiometabolic segment is anticipated to expand at a decent pace till 2032. With the rising prevalence of cardiovascular diseases and diabetes worldwide, there is a growing need for rapid and reliable diagnostic solutions in primary care settings. Companies are investing heavily in the development of POC diagnostic tests for conditions such as cardiac markers, lipid panels, and HbA1c, empowering healthcare providers to make timely interventions and improve patient outcomes.

The diagnostic centers segment is poised to grow robustly through 2032, as they offer a wide range of tests and services to patients in their local communities. With advancements in technology and the increasing availability of portable diagnostic devices, diagnostic centers are now able to offer an expanded menu of POC tests, catering to the diverse needs of patients and healthcare providers alike. As a result, diagnostic centers are poised to experience significant growth in the coming years.

Asia Pacific primary care point-of-care (POC) diagnostics market is set to gain prominence during the study period, propelled by the large population base, coupled with rising healthcare expenditures, and increasing awareness about preventive healthcare. Countries such as China, India, and Japan are witnessing a rapid expansion of their healthcare infrastructure, with a growing number of primary care clinics and diagnostic centers adopting POC testing technologies, thereby fueling industry growth.